Related Experiment Video
Updated: Apr 24, 2026
12:18
LINE-1 Methylation Analysis in Mesenchymal Stem Cells Treated with Osteosarcoma-Derived Extracellular Vesicles
Published on: February 1, 2020
5.1K
Microarray-based DNA methylation study of Ewing's sarcoma of the bone
Hye-Rim Park1, Woon-Won Jung2, Hyun-Sook Kim3
1Department of Pathology, College of Medicine, Hallym University, Anyang, Gyeonggi 431-070, Republic of Korea.
Oncology Letters
|September 10, 2014
Summary
This study identified 92 hypermethylated genes in Ewing's sarcoma, revealing a potential link between DNA methylation patterns and cancer development. Higher overall methylation was observed in non-survivors, suggesting methylation
Area of Science:
- Epigenetics
- Oncology
- Molecular Biology
Background:
- DNA methylation alterations are key in cancer.
- Previous Ewing's sarcoma epigenetic studies were limited in scope.
- Comprehensive methylation profiling is needed.
Purpose of the Study:
- To identify novel DNA methylation markers in Ewing's sarcoma.
- To conduct a comprehensive epigenetic analysis using microarray technology.
Main Methods:
- Microarray analysis of 1,505 CpG sites across 807 cancer-related genes.
- Utilized the Illumina GoldenGate Methylation Cancer Panel I.
- Analyzed 69 Ewing's sarcoma samples and 14 controls.
Main Results:
- Identified 92 significantly hypermethylated genes in Ewing's sarcoma.
- Hypermethylated genes were primarily involved in cell adhesion, regulation, development, and signal transduction.
- Overall methylation was significantly higher in non-survivors (P=0.0322).
Conclusions:
- Detected a distinct DNA methylation profile in Ewing's sarcoma.
- Identified 92 significantly hypermethylated genes.
- Methylation may play a role in Ewing's sarcoma development and progression.
